FACEBOOK aims at disease information sharing
Release date: 2014-10-10
The market's demand for medical information is gradually shifting from objective information from third parties to information with individual cases, because information with individual cases and experiences is more practical, with higher credibility and relevance. Looking at this trend, more and more companies want to enter this field, and social media carries a lot of personal information and is not willing to let go of this opportunity.
According to Reuters, social networking site Facebook is trying to enter the health care arena, trying to create an online "support community" to allow users to share various disease information into social circles. Facebook is also considering creating a “preventive health care†app to help people improve their lifestyles.
Another case is WiserTogether, a company that generates a database of disease treatments through surveys of patients and doctors, from data interviews with patients or voluntary publication of cases and treatments. After establishing a disease database, WiserTogether is based on the disease. Provide treatment advice to users. Its profit model is to charge employers and insurance companies, as an add-on project to expose this database to employees and members.
The actions and developments of the two companies show that medical information is shifting from simple third-party information that is not well-recognized to individuals to case-based information that is more informative for individuals. As a social media, Facebook wants to enter this field, its advantages are powerful social platforms and circles, as well as its strong data collection and dissemination capabilities. But this is also a double-edged sword, and its disadvantages are also here.
From the community of patients like PatientslikeMe to the disease library like WiserTogether, the core is actually based on relatively strangers. But Facebook is different, starting with acquaintances and close people. In such a familiar circle, patients may be embarrassed to share their disease information, because it means that people around you and people close to you know their condition. And if it is a strange community, there is no such awkwardness. Therefore, although Facebook's platform is large, it is very challenging to turn it around.
Another point of Facebook is the high degree of credibility, which is also because of the relatively high level of trust that is recommended by relatively familiar friends. There is also the advantage of the possibility of treating the disease. But unlike WiserTogether, WiserTogether can package the disease database and share it with employers and employees to help them choose information for disease treatment, but Facebook includes many colleagues and highly relevant professional partners, sharing disease information in this circle. The opposite effect, which is the inevitable silence caused by closeness.
The profit model of disease data still needs to be mature. At present, websites like PatientslikeMe are mainly used as research and development and marketing reference by providing anonymous patient information drug companies and medical device companies. The biggest problem with this approach is the accuracy of how to extract meaningful parts from the block information and how to ensure the user's information security. The same two problems exist for a website like Facebook.
Although the disease data with individual cases is favored by all parties, its operation is still very difficult. At present, it seems that the possibility of sharing private medical information by strange communities may be greater than that of familiar communities, and the profit model is still horizontal. In front of a hurdle.
Source: Village Diary
The RNA purification kit is used to purify and recover RNA molecules transcribed in vitro and total RNA extracted from various materials, which can effectively remove contaminating impurities in RNA samples. The recovery rate of this product can reach 80%, and the OD260/OD280 ratio of the obtained RNA is generally about 2.0, which can be directly used in subsequent sensitive experiments (such as microarray analysis, fluorescence RT-PCR, etc.). With the deepening of transcriptomics, the complexity of RNA types, expression regulation and functions is far beyond our imagination.
Removing ribosomal RNAs that account for more than 80% helps to focus sequencing on less abundant but informative RNAs. At present, the removal of rRNA is mainly through the combined use of probe and RNase H. The processed RNA will be mixed with many digestion products, enzymes and ions, which is not conducive to the subsequent construction of RNA library. Take the Columnar RNA Purification Kit as an example. Trizol is a ready-to-use reagent that can be used to purify total RNA from tissues and cells. This is a single-phase solution of phenol and guanidine isothiocyanate that facilitates lysis of tissues and cells, inhibiting RNases to maintain RNA integrity.
Covid-19 Nucleic Acid Extraction Reagent,Nucleic Acid Extraction Reagent Kits,Dna Purification Kit,Rna Purification Kit
Jilin Sinoscience Technology Co. LTD , https://www.jlgkscience.com